Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational
Official Title: A Prospective and Retrospective Data Collection Study to Evaluate Outcomes in Males ≤17 Years of Age Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Cerebral <
Brief Summary: Study ALD 103 is a multi-site, global, data collection study that is designed to evaluate safety and efficacy of allogenic hematopoietic stem cell transplantation (allo-HSCT) in patients with CALD aged 17 or younger.